We're delighted to add our latest Educational Series titled: Advancing CLL Care: EHA 2025 and 2024 ESMO Guidelines Update. This Educational Review describes the latest EHA 2025 and 2024 ESMO guideline updates, offering a comprehensive understanding of how these updates impact CLL care, and aiding healthcare professionals in making informed treatment decisions for their patients.
It also includes guiding commentary from Professor John Seymour AM, a clinical haematologist and until 2025 was the Director of the Department of Haematology of the Peter MacCallum Cancer Centre & the Royal Melbourne Hospital in Melbourne, Australia.
Please login below to download this issue (PDF)